Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Delirium | 3 | 2018 | 1061 | 0.75 | Why? |
| Tumor Necrosis Factors | 1 | 2018 | 28 | 0.74 | Why? |
| Anesthetics, Dissociative | 1 | 2018 | 21 | 0.72 | Why? |
| Chromatography, Gel | 1 | 2018 | 71 | 0.72 | Why? |
| Shock, Hemorrhagic | 1 | 2019 | 81 | 0.71 | Why? |
| Pulmonary Surgical Procedures | 1 | 2017 | 17 | 0.69 | Why? |
| Rupture | 1 | 2017 | 40 | 0.68 | Why? |
| Liver Failure | 1 | 2021 | 266 | 0.68 | Why? |
| Haloperidol | 1 | 2018 | 78 | 0.68 | Why? |
| Ketamine | 1 | 2018 | 112 | 0.62 | Why? |
| Recombinant Fusion Proteins | 2 | 2018 | 919 | 0.60 | Why? |
| Chromatography, Affinity | 1 | 2018 | 310 | 0.60 | Why? |
| Dexmedetomidine | 1 | 2017 | 130 | 0.60 | Why? |
| Propofol | 1 | 2017 | 172 | 0.57 | Why? |
| Microcirculation | 1 | 2019 | 447 | 0.56 | Why? |
| Diaphragm | 1 | 2017 | 232 | 0.53 | Why? |
| Fluid Therapy | 1 | 2019 | 628 | 0.53 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.47 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.45 | Why? |
| Antibodies | 1 | 2018 | 846 | 0.44 | Why? |
| Acute Kidney Injury | 2 | 2021 | 5762 | 0.38 | Why? |
| Antipsychotic Agents | 1 | 2018 | 887 | 0.38 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 5002 | 0.37 | Why? |
| Shock, Septic | 1 | 2019 | 1313 | 0.37 | Why? |
| Cardiac Surgical Procedures | 2 | 2018 | 1931 | 0.34 | Why? |
| Switzerland | 6 | 2021 | 2738 | 0.32 | Why? |
| Postoperative Complications | 3 | 2018 | 5861 | 0.28 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.22 | Why? |
| Neurofilament Proteins | 1 | 2021 | 202 | 0.20 | Why? |
| Hyponatremia | 2 | 2021 | 371 | 0.20 | Why? |
| Central Venous Pressure | 1 | 2019 | 24 | 0.20 | Why? |
| Hypernatremia | 1 | 2021 | 182 | 0.20 | Why? |
| Radiotherapy Dosage | 1 | 2021 | 428 | 0.19 | Why? |
| Heart Failure | 1 | 2021 | 6638 | 0.19 | Why? |
| Clinical Trials, Phase IV as Topic | 1 | 2018 | 75 | 0.18 | Why? |
| Confidence Intervals | 1 | 2021 | 744 | 0.18 | Why? |
| Peptic Ulcer | 1 | 2018 | 85 | 0.18 | Why? |
| Histidine | 1 | 2018 | 72 | 0.18 | Why? |
| Veins | 1 | 2019 | 168 | 0.18 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.18 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 47 | 0.17 | Why? |
| Ventricular Function, Right | 1 | 2021 | 388 | 0.17 | Why? |
| Microglia | 1 | 2020 | 357 | 0.16 | Why? |
| Lipocalin-2 | 1 | 2018 | 156 | 0.16 | Why? |
| Thrombosis | 1 | 2018 | 7504 | 0.15 | Why? |
| Oxygen Consumption | 1 | 2021 | 711 | 0.15 | Why? |
| Ventilator Weaning | 1 | 2021 | 536 | 0.15 | Why? |
| Crowding | 1 | 2021 | 731 | 0.14 | Why? |
| Multicenter Studies as Topic | 2 | 2021 | 2437 | 0.14 | Why? |
| Aorta, Thoracic | 1 | 2017 | 271 | 0.14 | Why? |
| Hand | 1 | 2019 | 449 | 0.14 | Why? |
| Alanine Transaminase | 1 | 2021 | 1329 | 0.14 | Why? |
| Creatinine | 1 | 2021 | 1443 | 0.14 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.13 | Why? |
| Aortic Aneurysm, Thoracic | 1 | 2017 | 161 | 0.13 | Why? |
| Respiratory Therapy | 1 | 2021 | 918 | 0.13 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 226 | 0.13 | Why? |
| Oligopeptides | 1 | 2018 | 576 | 0.13 | Why? |
| Proton Pump Inhibitors | 1 | 2018 | 377 | 0.13 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.13 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.13 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.12 | Why? |
| Ligands | 1 | 2018 | 1300 | 0.12 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2018 | 669 | 0.12 | Why? |
| Aneurysm, Dissecting | 1 | 2017 | 303 | 0.12 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.11 | Why? |
| Fatal Outcome | 1 | 2021 | 3438 | 0.11 | Why? |
| Hemodynamics | 1 | 2019 | 1562 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.10 | Why? |
| Patient Positioning | 1 | 2021 | 1505 | 0.10 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.10 | Why? |
| Length of Stay | 4 | 2021 | 11042 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.09 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.09 | Why? |
| Humans | 25 | 2021 | 930598 | 0.09 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.08 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Heparin | 1 | 2018 | 2600 | 0.07 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.07 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.07 | Why? |
| Sleep | 1 | 2017 | 2695 | 0.07 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.07 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2021 | 10649 | 0.06 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.06 | Why? |
| Critical Care | 3 | 2021 | 14081 | 0.06 | Why? |
| Glasgow Outcome Scale | 1 | 2021 | 56 | 0.06 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.06 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Neuropathology | 1 | 2020 | 95 | 0.05 | Why? |
| Supine Position | 1 | 2021 | 158 | 0.05 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2021 | 350 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.05 | Why? |
| Astrocytes | 1 | 2020 | 298 | 0.04 | Why? |
| Lung | 3 | 2021 | 31049 | 0.04 | Why? |
| Female | 12 | 2021 | 380317 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2018 | 381 | 0.04 | Why? |
| Paraplegia | 1 | 2017 | 38 | 0.04 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2020 | 603 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Pulmonary Edema | 1 | 2021 | 430 | 0.04 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.04 | Why? |
| Blood Vessel Prosthesis | 1 | 2017 | 115 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Blood Pressure Determination | 1 | 2019 | 450 | 0.04 | Why? |
| Operative Time | 1 | 2017 | 450 | 0.04 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.04 | Why? |
| Hypothermia, Induced | 1 | 2017 | 176 | 0.04 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2021 | 1475 | 0.03 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.03 | Why? |
| Shock, Cardiogenic | 1 | 2021 | 700 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.03 | Why? |
| Renal Replacement Therapy | 1 | 2021 | 1530 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Kidney Diseases | 1 | 2021 | 1434 | 0.03 | Why? |
| Stents | 1 | 2017 | 916 | 0.02 | Why? |
| Prone Position | 1 | 2021 | 1861 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2019 | 2955 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Triage | 1 | 2021 | 7151 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Siegemund's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(229)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_